BMY vs STKL · P/E 17, rev $24.46B vs P/E 50, rev $723.7M
Bristol-Myers Squibb Company (BMY) versus SunOpta Inc. (STKL) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
SunOpta Inc. (STKL) is a beverages - non-alcoholic company listed on NASDAQ.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported STKL revenue for 2024-12-28 was $723.7M. Net income was -$17.4M. STKL currently screens at market cap $771.0M and trailing P/E 50.0.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. STKL currently screens at market cap $771.0M and trailing P/E 50.0.
Not investment advice. Open the BMY and STKL stock pages for the full models.
Not investment advice.